{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260618749080/en/Organon-and-Samsung-Bioepis-Expand-Agreement-to-Commercialize-PYZCHIVA%C2%AE-ustekinumab-a-Biosimilar-Referencing-STELARA%C2%AE-ustekinumab-in-Canada", "message": "News view counter 806780 successfully enlarged"}